Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$390K Sell
4,604
-4,643
-50% -$374K 0.12% 341
2026
Q1
$654K Buy
9,247
+166
+2% +$12.4K 0.19% 126
2025
Q4
$717K Buy
+9,081
New +$719K 0.24% 97

Other funds holding MET

AlphaGrep UK's MET Position: Q2 2026 in Review

AlphaGrep UK reduced its MetLife (MET) stake by 50% in Q2 2026, selling an estimated $374K and leaving 4,604 shares worth $390K. The position accounts for 0.12% of the portfolio, ranked #341.

AlphaGrep UK first reported a position in MET in Q4 2025 and has held it in 3 quarters since. The position peaked at $717K in Q4 2025. 1,378 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • AlphaGrep UK held 4,604 shares of MetLife worth $390K as of Q2 2026.
  • AlphaGrep UK sold 4,643 MetLife shares in Q2 2026, an estimated $374K.
  • MetLife made up 0.12% of AlphaGrep UK's portfolio in Q2 2026, its #341 holding.
  • AlphaGrep UK first reported a position in MetLife in Q4 2025 and has held it in 3 quarters since.
  • AlphaGrep UK's MetLife position peaked at $717K in Q4 2025.
  • 1,378 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.